Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Boomerang Medical

Request full access

A bioelectronic medicine company targeting the treatment of autoimmune diseases

Mountain View, United StatesFounded 2021Biotech & Life Sciences

About Boomerang Medical

Boomerang Medical is a clinical-stage medical device company that is developing a bioelectronic therapy for the treatment of autoimmune diseases. The company's initial focus is on inflammatory bowel disease (IBD), a chronic inflammatory condition of the gastrointestinal tract that affects millions of people worldwide.

Boomerang's therapy is based on the principle of neuromodulation, which involves the use of electrical stimulation to modulate the activity of the nervous system. The company has developed a proprietary neurostimulation device that is implanted in the wrist and delivers electrical pulses to the median nerve. This stimulation is intended to activate the body's natural anti-inflammatory reflex, which helps to reduce inflammation and improve symptoms in patients with IBD.

The company is currently conducting a pilot study to evaluate the safety and efficacy of its therapy in patients with IBD. The study is being conducted at multiple sites in the United States and is expected to enroll up to 60 patients. Boomerang has received FDA approval for its Investigational Device Exemption (IDE) application, which allows the company to conduct its pilot study.

Source: Dealroom company data

At a glance

Status
Operational
Employees
18
Open positions
None listed
Dealroom signal
81.6/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Sep 2025 $20M $80M Hatteras Venture Partners · Arboretum Ventures ↗
SERIES A✓Equity / VC Nov 2022 $15M $60M Hatteras Venture Partners · Arboretum Ventures ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Boomerang Medical website traffic

Latest recorded traffic for Boomerang Medical is 890 monthly website visits, up 27.1% over the last three months. Boomerang Medical's team grew 28.6% over the past year.

Latest monthly visits890 3-month web change+27.1% 1-year team growth+28.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Harness TherapeuticsA private biotechnology company, headquartered in Cambridge-UK, focused on the development of a novel class of therapeutic RNAs Babraham, United Kingdom Operational 5 $35M $90M
Ziphius VaccinesAddresses urgent global public health needs by developing mRNA-based vaccines Ghent, Belgium Operational
KimialysDeveloper of an analytical device intended to offer products based on innovative surface chemistry in the field of biosensors Paris, France Operational
SideROSFocused on accelerated development of innovative small molecules targeting tumour cells metabolism in high-risk cancers Paris, France Closed
AntegenesGenetic tests for personalized cancer risk prevention Tartu, Estonia Operational
Brenus PharmaProducing the widest panel of tumor associated antigens and resistance markers with a chemical labeling enable to induce cell death by patients' immune system Clermont-Ferrand, France Operational
Akston BiosciencesLeverages its core expertise of designing novel fusion proteins to develop and manufacture new classes of biologic therapeutics for Type 1 diabetes (T1D) prevention, ultra-long acting insulin therapy, and vaccines Beverly, United States Operational
Exeliom BiosciencesDeveloping single bacterial strain drug candidates to deliver first-in-class microbiome-based therapeutics Dijon, France Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Boomerang Medical in the Mountain View ecosystem

Live from Dealroom

The Boomerang Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Arboretum Ventures

Series A1 investor entered at this stage

  • Hatteras Venture Partners
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Boomerang Medical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Boomerang Medical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.